Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Stroke Prevention in Atrial Fibrillation: The Role of Oral Anticoagulation.

Mtwesi V, Amit G.

Med Clin North Am. 2019 Sep;103(5):847-862. doi: 10.1016/j.mcna.2019.05.006. Review.

PMID:
31378330
2.

Evaluating the Effect of Comprehensive Intervention on Cerebro-Vascular Function in Population at High Risk of Stroke.

Liu X, Gu Y, Zhang Y, Zhang Y, Tan X.

J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2543-2554. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.003. Epub 2019 Jul 9.

PMID:
31296475
3.

A Narrative Review of Nonvitamin K Antagonist Oral Anticoagulant Use in Secondary Stroke Prevention.

Caso V, Masuhr F.

J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2363-2375. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.017. Epub 2019 Jul 5. Review.

4.

Closing the gap on patent foramen ovale and cryptogenic stroke.

Darmoch F, Al-Khadra Y, Bacha HM, Soud M, Alraies MC.

Expert Rev Cardiovasc Ther. 2019 Jun;17(6):389-394. doi: 10.1080/14779072.2019.1627875. Epub 2019 Jun 11. Review.

PMID:
31184225
5.

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators.

N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.

PMID:
31091372
6.

Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial.

Lee CH, Jung KH, Cho DJ, Jeong SK.

BMC Neurol. 2019 May 1;19(1):82. doi: 10.1186/s12883-019-1315-5.

7.

Edoxaban for the prevention of stroke in patients with atrial fibrillation.

Cervantes CE, Merino JL, Barrios V.

Expert Rev Cardiovasc Ther. 2019 Apr;17(4):319-330. doi: 10.1080/14779072.2019.1598263. Epub 2019 Mar 27. Review.

PMID:
30897988
8.

The Fragility Index in Randomized Controlled Trials for Patent Foramen Ovale Closure in Cryptogenic Stroke.

Topcuoglu MA, Arsava EM.

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1636-1639. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.029. Epub 2019 Mar 16. Review.

PMID:
30890394
9.

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL; CABANA Investigators.

JAMA. 2019 Apr 2;321(13):1261-1274. doi: 10.1001/jama.2019.0693.

10.

Recent advances in the treatment of carotid artery disease.

Liang P, Wu WW, Schermerhorn ML.

J Cardiovasc Surg (Torino). 2019 Jun;60(3):345-353. doi: 10.23736/S0021-9509.19.10922-6. Epub 2019 Mar 4. Review.

PMID:
30845790
11.

Technical improvements in carotid revascularization based on the mechanism of procedural stroke.

Fassaert LM, de Borst GJ.

J Cardiovasc Surg (Torino). 2019 Jun;60(3):313-324. doi: 10.23736/S0021-9509.19.10918-4. Epub 2019 Mar 1. Review.

PMID:
30827087
12.

Cryptogenic stroke - How to make sense of a non-diagnostic entity.

Schulz UG.

Maturitas. 2019 Apr;122:44-50. doi: 10.1016/j.maturitas.2019.01.004. Epub 2019 Jan 11. Review.

PMID:
30797529
13.

Identifying asymptomatic patients at high-risk for stroke.

Gaba K, Bulbulia R.

J Cardiovasc Surg (Torino). 2019 Jun;60(3):332-344. doi: 10.23736/S0021-9509.19.10912-3. Epub 2019 Feb 20. Review.

PMID:
30785251
14.

Should we screen for atrial fibrillation?

Lown M, Moran P.

BMJ. 2019 Feb 13;364:l43. doi: 10.1136/bmj.l43. No abstract available.

PMID:
30760476
15.

Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review.

Pallazola VA, Kapoor RK, Kapoor K, McEvoy JW, Blumenthal RS, Gluckman TJ.

Vasc Med. 2019 Apr;24(2):141-152. doi: 10.1177/1358863X18819816. Epub 2019 Feb 12. Review.

PMID:
30755150
16.

Cerebrovascular Disease: Primary and Secondary Stroke Prevention.

Caprio FZ, Sorond FA.

Med Clin North Am. 2019 Mar;103(2):295-308. doi: 10.1016/j.mcna.2018.10.001. Epub 2018 Nov 28. Review.

PMID:
30704682
17.

Clinical Impact of Oral Anticoagulation in Patients with Atrial High-rate Episodes.

Marinheiro R, Parreira L, Amador P, Lopes C, Fernandes A, Mesquita D, Farinha J, Fonseca M, Duarte T, Caria R.

J Stroke Cerebrovasc Dis. 2019 Apr;28(4):971-979. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.019. Epub 2019 Jan 11.

PMID:
30642667
18.

Carotid Endarterectomy with Autoarterial Remodeling of Bifurcation of the Common Carotid Artery and Carotid Endarterectomy with Patch Closure: Comparison of Methods.

Ignatenko P, Novikova O, Gostev A, Starodubtsev V, Zeidlits G, Kuznetsov K, Starodubtseva A, Karpenko A.

J Stroke Cerebrovasc Dis. 2019 Mar;28(3):741-750. doi: 10.1016/j.jstrokecerebrovasdis.2018.11.017. Epub 2018 Dec 11.

PMID:
30545718
19.

Pulse pressure and perioperative stroke.

Al-Qamari A, Adeleke I, Kretzer A, Hogue CW.

Curr Opin Anaesthesiol. 2019 Feb;32(1):57-63. doi: 10.1097/ACO.0000000000000673. Review.

PMID:
30543556
20.

Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial.

Sánchez LM, Nieves RM, Latham T, Stuber S, Luden JR, Urcuyo GS, Berges ME, Florencio C, Gonzalez C, Del Villar P, Lane A, Schultz W, Jeste N, Mena R, Ware RE.

Blood Adv. 2018 Nov 30;2(Suppl 1):50-53. doi: 10.1182/bloodadvances.2018GS110818. No abstract available.

Supplemental Content

Loading ...
Support Center